Duy Dao

Dr. Duy Dao

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2018 in The American Journal of Pathology
Verified
Journal Article
Closed access
DDDuy Dao
Duy Dao
LALorenzo Anez-Bustillos
Lorenzo Anez-Bustillos
RARosalyn M. Adam
Rosalyn M. Adam
MPMark Puder
Mark Puder
DBDiane R. Bielenberg
Diane R. Bielenberg

1 January 2016 in The Journal of Heart and Lung Transplantation
Verified
Journal Article
Closed access
MSMary Lynette Stein
Mary Lynette Stein
DDDuy Dao
Duy Dao
LĐLan N. Đoàn
Lan N. Đoàn
OROlaf Reinhartz
Olaf Reinhartz
KMKatsuhide Maeda
Katsuhide Maeda
DRDavid N. Rosenthal
David N. Rosenthal

16 August 2016 in Nutrition in Clinical Practice
Verified
Journal Article
Closed access
PDF file
LALorenzo Anez‐Bustillos
Lorenzo Anez‐Bustillos
DDDuy Dao
Duy Dao
MBMeredith A. Baker
Meredith A. Baker
GFGillian L. Fell
Gillian L. Fell
MPMark Puder
Mark Puder
KGKathleen M Gura
Kathleen M Gura

1 June 2018 in Clinical Nutrition
Verified
Journal Article
Closed access
LALorenzo Anez-Bustillos
Lorenzo Anez-Bustillos
DDDuy Dao
Duy Dao
GFGillian L. Fell
Gillian L. Fell
MBMeredith A. Baker
Meredith A. Baker
KGKathleen M Gura
Kathleen M Gura
MPMark Puder
Mark Puder

13 August 2019 in Annals of Surgery
Verified
Journal Article
Closed access
DDDuy Dao
Duy Dao
CBCarmen M. Burgos
Carmen M. Burgos
MHMatthew T. Harting
Matthew T. Harting
KLKevin P. Lally
Kevin P. Lally
PLPamela A. Lally
Pamela A. Lally
TBTerry L. Buchmiller
Terry L. Buchmiller
Objective: To determine the optimal timing of congenital diaphragmatic hernia (CDH) repair after extracorporeal membrane oxygenation (ECMO) cannulation Summary Background Data: The timing of CDH repair after ECMO cannulation remains a controversial topic due to studies with low power or strong selection bias. Methods: This is a 2-aim retrospective cohort study based on the CDH Study Group registry for the period of 2007–2017. Aim 1—Compare On versus After ECMO repair. Aim 2—Compare Early versus Late repair on ECMO. In order to minimize selection bias and account for non-repairs, subjects in each aim were stratified into study groups based on their treatment center's characteristics. In each aim, the study groups were matched based on propensity score (PS). The main outcomes included mortality rate and incidence of non-repair. Results: In aim 1, 136 patients remained in each group after PS matching. Compared to the After ECMO group, patients in the On ECMO group demonstrated a lower mortality rate, hazard ratio (HR) 0.54 (0.38, 0.77) (P < 0.001), and lower incidence of non-repair, 5.9% versus 33.8% (P < 0.001). In aim 2, 77 patients remained in each group after PS matching. Compared to the Late group, Early repair of CDH on ECMO was associated with a lower mortality rate, HR 0.51 (0.33, 0.77) (P = 0.002), and lower incidence of non-repair, 9.1% versus 44.2% (P < 0.001). Conclusions: The approach of early repair after ECMO cannulation is associated with improved survival compared to delayed surgical correction.

1 July 2012 in Circulation: Heart Failure
Verified
Journal Article
Closed access
SHSeth A. Hollander
Seth A. Hollander
DBDaniel Bernstein
Daniel Bernstein
JYJustin Yeh
Justin Yeh
DDDuy Dao
Duy Dao
HSHeather Y. Sun
Heather Y. Sun
DRDavid Rosenthal
David Rosenthal
Background—: We hypothesized that children with dilated cardiomyopathy who require hospital admission are at increased risk for death or transplantation during their first hospitalization and in the first year that follows. We also assessed the value of routine data collected during that time to predict death or the need for transplantation prior to discharge and within 1 year of admission. Methods and Results—: We conducted a retrospective review of 83 pediatric patients with dilated cardiomyopathy whose initial hospitalization fell between 2004 and 2009. The mean age at hospitalization was 7 years. The majority of patients demonstrated moderate or severe left ventricular dysfunction on initial echocardiogram (80%) and/or the need for intravenous inotropes within 7 days of hospital admission (69%). Five patients (6%) died, and 15 (18%) were transplanted in the initial hospitalization. At 1 year, 11/71 (15%) had died, and 27/71 (38%) were transplanted. The overall freedom from death, transplantation, or rehospitalization at 1 year following admission was 21%. Fractional shortening, left ventricular ejection fraction, serum cholesterol, uric acid, mixed venous saturation, and atrial filling pressures were all predictive of death or transplantation during the initial hospitalization. Left ventricular ejection fraction was predictive of death or transplantation at 1 year. Conclusions—: The first hospitalization for dilated cardiomyopathy marks a period of high risk for clinical decline, end stage heart failure, and the need for cardiac transplantation. Echocardiographic function and hemodynamic and serum measurements may aid in predicting outcomes. Despite medical management, most patients will be rehospitalized and/or require cardiac transplantation within 1 year of admission.